The Trump administration has introduced a deal permitting sufferers to purchase prescribed drugs at discounted costs through a brand new web site operated by the federal authorities.The settlement with pharmaceutical big Pfizer will see costs for some medicines slashed by as much as 85% on the direct-to-consumer TrumpRx web site, the White Home stated in a press convention on Tuesday.Pfizer additionally agreed to decrease prescription drug costs for the state-run Medicaid program, the federal government’s public medical health insurance plan for low-income Individuals, in a transfer that can see the corporate keep away from paying tariffs.It comes after the US president introduced final week a 100% levy on branded or patented drug imports from 1 October.Pfizer is the primary pharmaceutical agency to settle a deal after Donald Trump despatched letters to 17 drug corporations in the summertime, giving them 60 days to answer his calls for for decrease costs – a deadline that expired this week. Throughout the press convention, Trump referred to a coverage geared toward aligning costs within the US with decrease ones overseas.He stated: “Pfizer is committing to supply all of their prescription medicines to Medicaid, and it will likely be on the most-favoured nations costs.” “It should have a huge effect on bringing Medicaid prices down.”He stated he anticipated extra offers with drug makers to be introduced.In an announcement on Tuesday, Pfizer stated nearly all of its major care medicine can be obtainable on TrumpRx, however didn’t disclose particular medicines.The corporate additionally stated it could make investments a further $70bn (£52bn) in US manufacturing, analysis and growth. Pfizer’s settlement is the newest instance of concessions from pharmaceutical corporations to keep away from Trump’s tariffs on branded medicine for 3 years.Albert Bourla, Pfizer’s chief government, stated: “We now have the knowledge and stability we want on two essential fronts, tariffs and pricing.”Pfizer shares rose practically 7% on Tuesday following the announcement.Trump conceded that drug costs could rise overseas due to his actions geared toward decreasing costs within the US. Eli Lilly, for instance, has stated it should increase drug costs in Europe “with a view to make them decrease” within the US.It’s unclear whether or not Trump’s push together with the direct-to-consumer web site, which is anticipated to launch early 2026, will truly convey down costs for American shoppers, since insurance coverage corporations and different middlemen additionally affect prices.
Trending
- Nielsen’s The Gauge Ratings for November 2025
- EU waters down plans to end new petrol and diesel car sales by 2035
- A Tale of Two Clocks: Making Both Brand Performance and Value Tick
- Former chancellor George Osborne joins OpenAI
- Color.io Shutting Down – Popular Film Emulation and Color Grading Tool Goes Offline December 31
- Kraft Heinz taps ex-Kellanova boss as new chief for looming break-up
- Can Buzzy Marketing Bring Back JCPenney? CMO Marisa Thalberg Is Betting on It
- Employment Rights Bill clears last parliamentary hurdle

